ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,593, issued on April 14, was assigned to Biomed Valley Discoveries Inc. (Kansas City, Mo.).

"Methods and compositions for treating non-ERK MAPK pathway inhibitor-resistant cancers" was invented by Saurabh Saha (Wellesley Hills, Mass.), Dean Welsch (Parkville, Mo.), Gary Decrescenzo (Parkville, Mo.) and Jeffrey Roix (Boston).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides, inter alia, methods, pharmaceutical compositions, and kits for treating or ameliorating the effects of a cancer in a subject, which cancer is refractory or resistant to non-ERK MAPK pathway inhibitor therapy. Also provided are methods for identifying a...